Whoever bought 4k of stock might know something we dont
Https://marketresearchblog.org/2024/03/united-state-and-canada-biosimulation-industry/
Https://www.share-talk.com/traders-cafe-with-zak-mir-bulletin-board-heroes-tuesday-23rd-april-2024/
Https://www.investorsobserver.com/news/qm-pr/5491698957879759
I believe the interim results are due at the end of this week. Let's see what they say.
I wouldn't be surprised if CDL and G2 merge in the near future. Cloudbreak's website is currently down, I guess watch this space.
Anyone know what the agenda is for the upcoming General Meeting?
Does anyone know what the agenda may be for the upcoming GM in February?
ππ’π¬π π¨π πππ² ππ₯ππ²ππ«π¬ :
List of key players:
Physiomics Plc, Genedata AG, Simulations Plus, Inc., VeriSIM Life, Schrodinger, Inc., SimBioSys, Cadence Design Systems, Inc., Certara, Inc., Dassault Systemes, INOSIM Software GmbH
From Pharmiweb.com article publish on Wednesday:
Biosimulation market size was valued at $2.5 billion in 2022, and is estimated to reach $10.6 billion by 2032, growing at a CAGR of 15.8% from 2023 to 2032. Biosimulation is quantitative drug development that powers decision making. Modeling and simulation are proven effective and efficient alternatives to real-world clinical trials. The result is enabling clients to make better medicines available to patients sooner.
Cloudbreabreak is a shareholder of Norseman
https://www.streetwisereports.com/article/2023/12/11/junior-secures-option-on-chile-copper-project-with-major-neighbors.html
This is moving up quickly
Surely the fact current directors Andrew Male and Paul Gurney will pay Β£136,156.50 out of their own pockets to sort out the outstanding debt is a positive indication.